Cortical complexity and gyrification patterns in Parkinson's disease. Issue 7 (7th May 2020)

• Record Type: Journal Article
• Authors: Li, Dan; Wang, Erlei; Jia, Yujing; Xu, Jin; Zhang, Zhongshuai; Jiang, Zhen; Luo, Weifeng
• Is Part Of: NeuroReport. Volume 31:Issue 7(2020)
• Publication Date: 2020-05-07
• Subjects: cortical complexity -- gyrification -- MRI -- Parkinson's disease; Neurosciences -- Periodicals; Nervous system -- Periodicals; Neurophysiology -- Periodicals; Nervous System Diseases -- Periodicals; Nervous System Physiological Phenomena -- Periodicals; Neurosciences -- Periodicals; 616.805
• DOI: 10.1097/WNR.0000000000001448
• Languages: English
• ISSNs: 0959-4965

Abstract

Abstract : This study aimed to investigate the cortical complexity and gyrification patterns in Parkinson's disease (PD) using local fractional dimension (LFD) and local gyrification index (LGI), respectively. In a cross-sectional study, LFD and LGI in 60 PD patients without dementia and 56 healthy controls (HC) were investigated using brain structural MRI data. LFD and LGI were estimated using the Computational Anatomy Toolbox (CAT12) and statistically analyzed between groups on a vertex level using statistical parametric mapping 12 (SPM12). Additionally, correlations between structural changes and clinical indices were further examined. PD patients showed widespread LFD reductions mainly in the left pre- and postcentral cortex, the left superior frontal cortex, the left caudal middle frontal cortex, the bilaterally superior parietal cortex and the right superior temporal cortex compared to HC. For LGI, there was no significant difference between PD and HC. In PD patients group, a significant negative correlation was found between LFD of the left postcentral cortex and duration of illness (DOI). Our results of widespread LFD reductions, but not LGI, indicate that LFD may provide a more sensitive diagnostic biomarker and encode specific information of PD. The significant negative correlation between LFD of the left postcentral cortex and DOI suggests that LFD may be a biomarker to monitor disease progression in PD.